PEMIGATINIB

PEMIGATINIB was reported 853 times

PEMIGATINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MYOEPITHELIAL CARCINOMA OF SALIVARY GLAND 1 0.5000
1 HIGH INTENSITY FOCUSED ULTRASOUND 1 0.3333
2 TUMOUR BIOPSY 1 0.2500
3 ADENOCARCINOMA OF SALIVARY GLAND 9 0.2308
4 STROKE-LIKE MIGRAINE ATTACKS AFTER RADIATION THERAPY 2 0.2000
5 RETROPERITONEAL NEOPLASM METASTATIC 5 0.1515
6 VASCULAR ACCESS SITE PRURITUS 1 0.0588
7 NAIL TOXICITY 17 0.0567
8 TRICHOMEGALY 2 0.0455
9 KIDNEY ABLATION 1 0.0455
10 CHOLANGIOCARCINOMA 62 0.0416
11 PHOSPHORUS METABOLISM DISORDER 2 0.0392
12 PHAEOCHROMOCYTOMA MALIGNANT 1 0.0385
13 CUTANEOUS CALCIFICATION 7 0.0383
14 ECCRINE CARCINOMA 1 0.0333
15 FIBROBLAST GROWTH FACTOR 23 INCREASED 2 0.0323
16 NAIL DEFORMATION 2 0.0299
17 HYPERPHOSPHATAEMIA 54 0.0251
18 HYPERCALCAEMIA OF MALIGNANCY 6 0.0221
19 SPINAL MYELOGRAM ABNORMAL 1 0.0192
20 SEROUS RETINOPATHY 2 0.0190
21 GLIONEURONAL TUMOUR 1 0.0185
22 ORAL TOXICITY 1 0.0179
23 HEPATOBILIARY CANCER 1 0.0167
24 CUTANEOUS T-CELL LYMPHOMA RECURRENT 1 0.0159
25 HAEMATOLOGICAL NEOPLASM 1 0.0145
26 BRAIN STEM GLIOMA 2 0.0132
27 TRICHIASIS 4 0.0126
28 ACUTE BIPHENOTYPIC LEUKAEMIA 1 0.0108
29 BLOOD PHOSPHORUS INCREASED 29 0.0106
30 ONYCHOLYSIS 16 0.0102
31 PLEURODESIS 1 0.0099
32 ASTROCYTOMA MALIGNANT 1 0.0097
33 CARBOHYDRATE ANTIGEN 19-9 INCREASED 5 0.0095
34 NAIL BED TENDERNESS 1 0.0088
35 BLOOD PHOSPHORUS ABNORMAL 4 0.0085
36 HYPERVITAMINOSIS D 1 0.0083
37 NAIL DISCOMFORT 1 0.0083
38 BACTERIAL DISEASE CARRIER 6 0.0082
39 GLIOBLASTOMA 14 0.0082
40 ADENOID CYSTIC CARCINOMA 1 0.0078
41 PARATHYROID TUMOUR MALIGNANT 1 0.0078
42 CHLOROPSIA 1 0.0078
43 BREAST ULCERATION 1 0.0072
44 SARCOMA METASTATIC 1 0.0072
45 SEROUS RETINAL DETACHMENT 6 0.0072
46 PORTAL VEIN OCCLUSION 1 0.0068
47 XEROPHTHALMIA 4 0.0068
48 CHALAZION 4 0.0062
49 SALIVARY HYPOSECRETION 1 0.0062
50 HEPATIC CALCIFICATION 1 0.0061
51 CALCIPHYLAXIS 11 0.0060
52 DRUG WITHDRAWAL CONVULSIONS 10 0.0056
53 SUBRETINAL FLUID 6 0.0055
54 NAIL DYSTROPHY 3 0.0054
55 CALCIUM METABOLISM DISORDER 1 0.0053
56 NASAL SINUS CANCER 1 0.0053
57 PULMONARY HILUM MASS 1 0.0053
58 RETINAL DEPOSITS 1 0.0049
59 T-CELL TYPE ACUTE LEUKAEMIA 1 0.0049
60 SYSTEMIC TOXICITY 1 0.0049
61 NAIL BED DISORDER 2 0.0047
62 CENTRAL SEROUS CHORIORETINOPATHY 3 0.0044
63 SQUAMOUS CELL CARCINOMA OF HEAD AND NECK 1 0.0043
64 INCREASED NEED FOR SLEEP 1 0.0043
65 HAIRY CELL LEUKAEMIA 1 0.0043
66 NAIL BED INFECTION 1 0.0042
67 EPIPHYSIOLYSIS 1 0.0040
68 RETINAL NEOVASCULARISATION 1 0.0040
69 INGUINAL MASS 1 0.0039
70 METASTASES TO SOFT TISSUE 1 0.0039
71 CHOLANGITIS INFECTIVE 1 0.0038
72 NAIL DISORDER 32 0.0037
73 TONGUE ERYTHEMA 3 0.0036
74 PRODUCT INFORMATION CONTENT COMPLAINT 1 0.0036
75 NAIL DISCOLOURATION 14 0.0036
76 BLOOD PHOSPHORUS DECREASED 13 0.0036
77 HEPATIC CANCER RECURRENT 1 0.0035
78 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 3 0.0034
79 CREATININE URINE INCREASED 1 0.0033
80 EYE INFECTION VIRAL 1 0.0031
81 ONYCHOMADESIS 13 0.0031
82 GASTRIC VARICES HAEMORRHAGE 1 0.0030
83 HYPERCREATINAEMIA 1 0.0030
84 ONYCHALGIA 3 0.0030
85 METASTATIC GASTRIC CANCER 1 0.0029
86 METASTASES TO CHEST WALL 1 0.0029
87 FUNGAL OESOPHAGITIS 2 0.0028
88 MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE 1 0.0027
89 OCULAR TOXICITY 3 0.0027
90 REACTIVE GASTROPATHY 1 0.0026
91 CRITICAL ILLNESS 2 0.0026
92 ASTROCYTOMA 1 0.0025
93 BILE DUCT CANCER 3 0.0025
94 NAIL OPERATION 1 0.0024
95 IMMUNE-MEDIATED RENAL DISORDER 1 0.0024
96 WOUND INFECTION BACTERIAL 1 0.0024
97 HYPOTONY OF EYE 1 0.0024
98 GLIOBLASTOMA MULTIFORME 2 0.0024
99 METASTASES TO PERITONEUM 6 0.0024
100 ABDOMINAL CAVITY DRAINAGE 1 0.0024
101 RETINAL PIGMENT EPITHELIOPATHY 1 0.0023
102 METASTASES TO PANCREAS 1 0.0023
103 SOFT TISSUE MASS 1 0.0022
104 GALLBLADDER RUPTURE 1 0.0022
105 RETINAL OEDEMA 4 0.0021
106 INTERVERTEBRAL DISC DISPLACEMENT 1 0.0019
107 BLOOD SODIUM ABNORMAL 2 0.0019
108 BODY FAT DISORDER 1 0.0018
109 URETHRITIS 1 0.0018
110 HOSPICE CARE 18 0.0018
111 NAIL INJURY 1 0.0018
112 URINARY TRACT INFECTION FUNGAL 1 0.0017
113 COLON INJURY 1 0.0017
114 RETINAL DETACHMENT 16 0.0017
115 SKIN NECROSIS 9 0.0017
116 INTRA-ABDOMINAL FLUID COLLECTION 3 0.0017
117 BILIARY TRACT INFECTION 1 0.0016
118 HYPERAESTHESIA TEETH 2 0.0016
119 BILIARY OBSTRUCTION 2 0.0015
120 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 1 0.0015
121 STENOTROPHOMONAS INFECTION 2 0.0015
122 CORNEAL ABRASION 2 0.0015
123 FLUID IMBALANCE 1 0.0014
124 NAIL INFECTION 2 0.0014
125 CALCINOSIS 3 0.0013
126 PERFORATED ULCER 1 0.0013
127 GROWTH OF EYELASHES 1 0.0013
128 SUPERINFECTION BACTERIAL 1 0.0013
129 DISEASE PROGRESSION 144 0.0012
130 HAND-FOOT-AND-MOUTH DISEASE 1 0.0012
131 SUPERFICIAL VEIN THROMBOSIS 1 0.0012
132 COLONIC ABSCESS 1 0.0012
133 ABDOMINAL LYMPHADENOPATHY 1 0.0012
134 BLOOD ALKALINE PHOSPHATASE ABNORMAL 1 0.0011
135 METASTASES TO ADRENALS 1 0.0011
136 RETINAL EXUDATES 1 0.0011
137 PRODUCT AVAILABILITY ISSUE 24 0.0011
138 BREAST MASS 7 0.0010
139 HYPERVIGILANCE 1 0.0010
140 TASTE DISORDER 21 0.0010
141 ANTIBIOTIC THERAPY 1 0.0010
142 HYPOGEUSIA 2 0.0010
143 GENE MUTATION 2 0.0010
144 FLUID INTAKE REDUCED 5 0.0010
145 BLEPHARITIS 4 0.0010
146 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 23 0.0010
147 GASTRIC PH DECREASED 1 0.0010
148 MICROCYTIC ANAEMIA 2 0.0010
149 METASTASES TO PLEURA 1 0.0010
150 OESOPHAGEAL VARICES HAEMORRHAGE 2 0.0009
151 NAIL GROWTH ABNORMAL 1 0.0009
152 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 1 0.0008
153 HYPOPHOSPHATAEMIA 6 0.0008
154 SUBCUTANEOUS HAEMATOMA 1 0.0008
155 ADENOCARCINOMA PANCREAS 1 0.0008
156 DACRYOSTENOSIS ACQUIRED 1 0.0008
157 TRANSITIONAL CELL CARCINOMA 1 0.0008
158 RETINAL DISORDER 2 0.0008
159 OESOPHAGEAL HAEMORRHAGE 1 0.0008
160 TONGUE DRY 1 0.0007
161 TONGUE DISCOMFORT 3 0.0007
162 BLOOD ELECTROLYTES DECREASED 1 0.0007
163 INTENSIVE CARE 1 0.0007
164 PANCREATIC CARCINOMA METASTATIC 2 0.0007
165 CHORIORETINOPATHY 1 0.0007
166 MENINGITIS BACTERIAL 1 0.0007
167 NONINFECTIVE GINGIVITIS 1 0.0007
168 BLOOD CALCIUM INCREASED 6 0.0007
169 AGEUSIA 17 0.0007
170 ANKLE OPERATION 1 0.0007
171 APRAXIA 1 0.0007
172 BLOOD PARATHYROID HORMONE DECREASED 1 0.0007
173 PALLIATIVE CARE 1 0.0007
174 ORAL MUCOSAL ERUPTION 1 0.0007
175 OSTEOMALACIA 1 0.0006
176 ORAL MUCOSAL ERYTHEMA 1 0.0006
177 ACUTE MYELOID LEUKAEMIA 10 0.0006
178 METASTASES TO LIVER 11 0.0006
179 DRY EYE 30 0.0006
180 TERMINAL STATE 4 0.0006
181 ENTEROBACTER INFECTION 1 0.0006
182 GENERAL PHYSICAL CONDITION ABNORMAL 4 0.0006
183 STOMATITIS 35 0.0006
184 MUCOSAL INFLAMMATION 15 0.0006
185 SOFT TISSUE INFECTION 1 0.0005
186 HYPERTRICHOSIS 1 0.0005
187 ADENOCARCINOMA OF COLON 1 0.0005
188 HYPOPROTEINAEMIA 1 0.0005
189 METASTASES TO LUNG 6 0.0005
190 HEPATIC MASS 1 0.0005
191 SKIN ULCER 13 0.0005
192 HYPERCALCAEMIA 6 0.0005
193 QUADRIPLEGIA 1 0.0005
194 SKIN INDURATION 1 0.0005
195 FOREIGN BODY SENSATION IN EYES 3 0.0005
196 GASTRIC CANCER STAGE IV 1 0.0005
197 METASTATIC NEOPLASM 2 0.0005
198 LIMB MASS 1 0.0005
199 PARONYCHIA 2 0.0005
200 GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0005
201 CLOSTRIDIUM TEST POSITIVE 1 0.0005
202 GASTROINTESTINAL ULCER 1 0.0005
203 CHOLESTATIC LIVER INJURY 1 0.0004
204 FEAR OF DEATH 1 0.0004
205 PERIARTHRITIS 1 0.0004
206 ONYCHOCLASIS 3 0.0004
207 DRY MOUTH 35 0.0004
208 LICHEN PLANUS 1 0.0004
209 RENAL FUNCTION TEST ABNORMAL 2 0.0004
210 INGROWING NAIL 1 0.0004
211 TRANSPLANT 1 0.0004
212 METASTASIS 3 0.0004
213 MYOPIA 1 0.0004
214 GASTROINTESTINAL OBSTRUCTION 1 0.0004
215 HAEMATOLOGICAL INFECTION 1 0.0004
216 SENSITIVE SKIN 3 0.0004
217 RETINAL ARTERY OCCLUSION 1 0.0004
218 ABDOMINAL INFECTION 1 0.0004
219 SKIN DISORDER 13 0.0004
220 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
221 HYPOALBUMINAEMIA 3 0.0004
222 BLOOD DISORDER 3 0.0004
223 ASCITES 11 0.0004
224 COMPRESSION FRACTURE 2 0.0004
225 DECREASED ACTIVITY 4 0.0004
226 METASTASES TO BONE 6 0.0004
227 ULCERATIVE KERATITIS 1 0.0004
228 NONSPECIFIC REACTION 2 0.0004
229 OCULAR DISCOMFORT 4 0.0004
230 SKIN HYPERTROPHY 1 0.0004
231 SKIN TOXICITY 2 0.0004
232 TUMOUR HAEMORRHAGE 1 0.0004
233 LIP PAIN 1 0.0003
234 EYELID MARGIN CRUSTING 1 0.0003
235 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
236 ESCHERICHIA SEPSIS 1 0.0003
237 BILIARY COLIC 1 0.0003
238 URINE OUTPUT DECREASED 3 0.0003
239 ALOPECIA 67 0.0003
240 ENERGY INCREASED 2 0.0003
241 EMERGENCY CARE 1 0.0003
242 KERATITIS 1 0.0003
243 DYSCHEZIA 1 0.0003
244 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
245 FIBROSIS 1 0.0003
246 PRODUCT DISTRIBUTION ISSUE 3 0.0003
247 NASAL DRYNESS 2 0.0003
248 HAEMATOTOXICITY 3 0.0003
249 LOSS OF THERAPEUTIC RESPONSE 1 0.0003
250 ORAL PAIN 7 0.0003
251 HEPATIC NEOPLASM 1 0.0003
252 VITREOUS FLOATERS 3 0.0003
253 SKIN MASS 2 0.0003
254 PROSTATE CANCER METASTATIC 1 0.0003
255 PLANTAR FASCIITIS 1 0.0003
256 METASTASES TO SPINE 1 0.0003
257 BLOOD BILIRUBIN INCREASED 8 0.0003
258 TONGUE ULCERATION 1 0.0003
259 THERAPY INTERRUPTED 21 0.0003
260 SUDDEN CARDIAC DEATH 1 0.0003
261 HYPOPNOEA 1 0.0003
262 ERYTHEMA NODOSUM 1 0.0003
263 FIBRIN D DIMER INCREASED 1 0.0003
264 MYELODYSPLASTIC SYNDROME 4 0.0003
265 HYPERTHYROIDISM 4 0.0003
266 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 8 0.0003
267 LEUKOENCEPHALOPATHY 1 0.0003
268 RETINOPATHY 1 0.0003
269 CHEMOTHERAPY 1 0.0003
270 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
271 BOWEL MOVEMENT IRREGULARITY 2 0.0003
272 HOSPITALISATION 40 0.0003
273 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
274 SPINAL CORD COMPRESSION 1 0.0003
275 STENT PLACEMENT 2 0.0002
276 FUNGAL SKIN INFECTION 1 0.0002
277 SPINAL COMPRESSION FRACTURE 2 0.0002
278 LABORATORY TEST ABNORMAL 7 0.0002
279 HYPERPYREXIA 1 0.0002
280 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
281 HEPATIC PAIN 1 0.0002
282 INTERVERTEBRAL DISC DISORDER 1 0.0002
283 CHAPPED LIPS 1 0.0002
284 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
285 NEOPLASM PROGRESSION 8 0.0002
286 GINGIVAL SWELLING 1 0.0002
287 TRANSAMINASES INCREASED 5 0.0002
288 GLOSSODYNIA 5 0.0002
289 DISEASE COMPLICATION 1 0.0002
290 HYPOMAGNESAEMIA 3 0.0002
291 PERFORMANCE STATUS DECREASED 1 0.0002
292 RENAL IMPAIRMENT 18 0.0002
293 IMPAIRED HEALING 7 0.0002
294 SKIN TIGHTNESS 1 0.0002
295 STAPHYLOCOCCAL INFECTION 7 0.0002
296 TUMOUR MARKER INCREASED 1 0.0002
297 ENTEROCOCCAL INFECTION 1 0.0002
298 THERAPY CHANGE 2 0.0002
299 DRY SKIN 27 0.0002
300 TOXIC ENCEPHALOPATHY 1 0.0002
301 AMMONIA INCREASED 1 0.0002
302 CACHEXIA 1 0.0002
303 VARICOSE VEIN 1 0.0002
304 HYPERBILIRUBINAEMIA 2 0.0002
305 FAILURE TO THRIVE 1 0.0002
306 HIP SURGERY 1 0.0002
307 CONSTIPATION 40 0.0002
308 BLOOD CALCIUM DECREASED 2 0.0002
309 OFF LABEL USE 155 0.0002
310 INTERNAL HAEMORRHAGE 2 0.0002
311 NEOPLASM 2 0.0002
312 SKIN ATROPHY 1 0.0002
313 MOUTH SWELLING 1 0.0002
314 BLOOD URIC ACID INCREASED 1 0.0002
315 MADAROSIS 2 0.0002
316 SKIN WARM 1 0.0002
317 HYPERCHLORHYDRIA 1 0.0002
318 CARDIAC PACEMAKER INSERTION 1 0.0002
319 PROTHROMBIN TIME PROLONGED 1 0.0002
320 TOOTHACHE 3 0.0002
321 DYSGEUSIA 12 0.0002
322 CHOLANGITIS 1 0.0002
323 DECREASED APPETITE 37 0.0002
324 BLOOD SODIUM DECREASED 3 0.0002
325 PHOTOPSIA 1 0.0002
326 DYSGRAPHIA 1 0.0002
327 APPETITE DISORDER 1 0.0002
328 METASTASES TO LYMPH NODES 1 0.0001
329 WRONG PRODUCT ADMINISTERED 1 0.0001
330 PRODUCT TASTE ABNORMAL 2 0.0001
331 EYE MOVEMENT DISORDER 1 0.0001
332 ECCHYMOSIS 1 0.0001
333 HAIR GROWTH ABNORMAL 1 0.0001
334 ORAL DISCOMFORT 2 0.0001
335 AUTOIMMUNE HEPATITIS 1 0.0001
336 DEFAECATION URGENCY 1 0.0001
337 MOUTH ULCERATION 3 0.0001
338 RED BLOOD CELL COUNT DECREASED 4 0.0001
339 LIVER FUNCTION TEST INCREASED 3 0.0001
340 CARDIOGENIC SHOCK 2 0.0001
341 VISUAL FIELD DEFECT 1 0.0001
342 TONGUE DISORDER 1 0.0001
343 PRODUCT DISPENSING ERROR 3 0.0001
344 MOUTH HAEMORRHAGE 1 0.0001
345 HYDRONEPHROSIS 1 0.0001
346 HEPATIC FAILURE 4 0.0001
347 FOOD ALLERGY 1 0.0001
348 APHTHOUS ULCER 1 0.0001
349 THERAPY PARTIAL RESPONDER 2 0.0001
350 PRODUCT USE COMPLAINT 2 0.0001
351 GINGIVAL PAIN 1 0.0001
352 HYPOTHYROIDISM 4 0.0001
353 BLOOD CREATININE INCREASED 8 0.0001
354 HICCUPS 1 0.0001
355 EYE DISORDER 4 0.0001
356 ESCHERICHIA INFECTION 1 0.0001
357 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
358 FUNGAL INFECTION 4 0.0001
359 LEUKOPENIA 6 0.0001
360 FLUID RETENTION 6 0.0001
361 VITAMIN D DECREASED 1 0.0001
362 DRUG RESISTANCE 3 0.0001
363 PSEUDOMONAS INFECTION 1 0.0001
364 SKIN HYPERPIGMENTATION 1 0.0001
365 ILL-DEFINED DISORDER 7 0.0001
366 DEHYDRATION 15 0.0001
367 GENERAL PHYSICAL HEALTH DETERIORATION 13 0.0001
368 GASTROINTESTINAL INFECTION 1 0.0001
369 MYELOSUPPRESSION 4 0.0001
370 OROPHARYNGEAL DISCOMFORT 1 0.0001
371 LIP DRY 1 0.0001
372 BRAIN NEOPLASM 1 0.0001
373 WOUND 3 0.0001
374 RENAL DISORDER 5 0.0001
375 ABORTION INDUCED 1 0.0001
376 FATIGUE 82 0.0001
377 CHOLESTASIS 2 0.0001
378 SKIN FISSURES 2 0.0001
379 PHARYNGEAL SWELLING 1 0.0001
380 INABILITY TO AFFORD MEDICATION 1 0.0001
381 DEATH 86 0.0001
382 FULL BLOOD COUNT DECREASED 2 0.0001
383 FEEDING DISORDER 2 0.0001
384 DRY THROAT 1 0.0001
385 TOOTH ABSCESS 1 0.0001
386 EAR DISCOMFORT 1 0.0001
387 THERAPY CESSATION 5 0.0001
388 HAEMOGLOBIN DECREASED 10 0.0001
389 SKELETAL INJURY 1 0.0001
390 WEIGHT FLUCTUATION 1 0.0001
391 PRODUCT ODOUR ABNORMAL 1 0.0001
392 SKIN EXFOLIATION 8 0.0001
393 NEUROPATHY PERIPHERAL 9 0.0001
394 FULL BLOOD COUNT ABNORMAL 1 0.0001
395 PLATELET COUNT DECREASED 10 0.0001
396 PULMONARY THROMBOSIS 1 0.0001
397 BLOOD GLUCOSE FLUCTUATION 1 0.0001
398 VISUAL ACUITY REDUCED 3 0.0001
399 HEPATOTOXICITY 2 0.0001
400 SKIN INFECTION 1 0.0001
401 INTESTINAL PERFORATION 1 0.0001
402 NEPHROPATHY TOXIC 1 0.0001
403 THERAPY NON-RESPONDER 4 0.0001
404 MALIGNANT NEOPLASM PROGRESSION 9 0.0001
405 NEPHROLITHIASIS 4 0.0001
406 PERICARDIAL EFFUSION 2 0.0001
407 ELECTROLYTE IMBALANCE 1 0.0001
408 SPINAL PAIN 1 0.0001
409 OCULAR HYPERAEMIA 4 0.0001
410 CATARACT 5 0.0001
411 HEPATIC CANCER 2 0.0001
412 LOCALISED INFECTION 2 0.0001
413 BURSITIS 1 0.0001
414 ENCEPHALOPATHY 2 0.0001
415 VISUAL IMPAIRMENT 10 0.0001
416 HEPATIC FUNCTION ABNORMAL 3 0.0001
417 EPISTAXIS 6 0.0001
418 INTESTINAL OBSTRUCTION 3 0.0001
419 HAEMATEMESIS 2 0.0001
420 HYPOPHAGIA 2 0.0001
421 SEIZURE 9 0.0001
422 PLATELET COUNT INCREASED 1 0.0001
423 NODULE 1 0.0001
424 FEAR 2 0.0001
425 PAIN OF SKIN 2 0.0001
426 SINUS CONGESTION 1 0.0001
427 UVEITIS 1 0.0001
428 GINGIVAL BLEEDING 1 0.0001
429 OSTEOPOROSIS 3 0.0001
430 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
431 PERIPHERAL COLDNESS 1 0.0001
432 MASS 1 0.0001
433 DIARRHOEA 46 0.0001
434 BLOOD TEST ABNORMAL 1 0.0001
435 DEVICE OCCLUSION 1 0.0001
436 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
437 SKIN REACTION 1 0.0001
438 BLINDNESS UNILATERAL 1 0.0001
439 INTENTIONAL DOSE OMISSION 2 0.0001
440 HYPERSOMNIA 2 0.0001
441 ANOSMIA 1 0.0001
442 MENTAL DISORDER 3 0.0001
443 BONE PAIN 4 0.0001
444 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
445 PULMONARY MASS 1 0.0001
446 IMMUNODEFICIENCY 1 0.0001
447 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
448 HAEMORRHAGE INTRACRANIAL 1 0.0001
449 BLOOD COUNT ABNORMAL 1 0.0001
450 PERIPHERAL SWELLING 10 0.0001
451 OROPHARYNGEAL PAIN 6 0.0001
452 LIMB DISCOMFORT 2 0.0001
453 MUSCULOSKELETAL CHEST PAIN 1 0.0001
454 ANKLE FRACTURE 1 0.0001
455 WEIGHT DECREASED 18 0.0001
456 BRAIN FOG 1 0.0001
457 DYSPHAGIA 6 0.0001
458 ULCER 1 0.0001
459 RASH ERYTHEMATOUS 3 0.0001
460 ABSCESS 1 0.0001
461 THROMBOCYTOPENIA 7 0.0001
462 ARTHRALGIA 26 0.0001
463 MOVEMENT DISORDER 2 0.0001
464 DRUG INTOLERANCE 6 0.0001
465 BLOOD POTASSIUM INCREASED 1 0.0001
466 VENTRICULAR TACHYCARDIA 1 0.0001
467 EYE PRURITUS 2 0.0001
468 VISION BLURRED 8 0.0001
469 NEUROTOXICITY 1 0.0001
470 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
471 DRUG ERUPTION 1 0.0001
472 THIRST 1 0.0001
473 GASTROINTESTINAL DISORDER 5 0.0001
474 ADVERSE DRUG REACTION 5 0.0001
475 RASH PRURITIC 3 0.0001
476 NAUSEA 43 0.0001
477 BLOOD GLUCOSE ABNORMAL 1 0.0001
478 CONJUNCTIVITIS 1 0.0001
479 SEPSIS 6 0.0001
480 HEPATIC STEATOSIS 1 0.0001
481 BACTERIAL INFECTION 1 0.0001
482 PHOTOPHOBIA 1 0.0001
483 GASTRIC ULCER 1 0.0001
484 PROTEINURIA 1 0.0001
485 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
486 EYE IRRITATION 3 0.0001
487 VOMITING 24 0.0001
488 KIDNEY INFECTION 1 0.0001
489 DYSPEPSIA 5 0.0001
490 SINUS DISORDER 1 0.0001
491 PAIN 31 0.0001
492 HAEMATOCRIT DECREASED 1 0.0001
493 BLOOD PRESSURE ABNORMAL 1 0.0001
494 THROMBOSIS 4 0.0000
495 PNEUMONIA 16 0.0000
496 BONE MARROW FAILURE 1 0.0000
497 DERMATITIS 1 0.0000
498 ANAEMIA 9 0.0000
499 EATING DISORDER 1 0.0000
500 HYPOACUSIS 2 0.0000
501 SKIN CANCER 1 0.0000
502 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
503 HYPOTENSION 9 0.0000
504 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
505 CHROMATURIA 1 0.0000
506 SHOCK 1 0.0000
507 HYPOKALAEMIA 2 0.0000
508 SWELLING 4 0.0000
509 ASTHENIA 16 0.0000
510 DISEASE RECURRENCE 2 0.0000
511 PRODUCT PRESCRIBING ERROR 1 0.0000
512 INFECTION 6 0.0000
513 PRESYNCOPE 1 0.0000
514 PRODUCT DOSE OMISSION ISSUE 12 0.0000
515 LIVER INJURY 1 0.0000
516 PAIN IN EXTREMITY 12 0.0000
517 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
518 ABDOMINAL PAIN LOWER 1 0.0000
519 GASTRIC CANCER 1 0.0000
520 ACUTE KIDNEY INJURY 6 0.0000
521 HEPATITIS 1 0.0000
522 ILLNESS 4 0.0000
523 INFLAMMATION 2 0.0000
524 ABDOMINAL PAIN 9 0.0000
525 DIPLOPIA 1 0.0000
526 ARTHRITIS 3 0.0000
527 JAUNDICE 1 0.0000
528 THROAT TIGHTNESS 1 0.0000
529 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
530 PNEUMONITIS 1 0.0000
531 SKIN LESION 1 0.0000
532 DRUG INEFFECTIVE 48 0.0000
533 HAEMATOCHEZIA 2 0.0000
534 TREATMENT FAILURE 3 0.0000
535 DIVERTICULITIS 1 0.0000
536 ARTHROPATHY 2 0.0000
537 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
538 PAIN IN JAW 1 0.0000
539 URINARY TRACT INFECTION 6 0.0000
540 HERPES ZOSTER 2 0.0000
541 LETHARGY 2 0.0000
542 PANCREATIC CARCINOMA 1 0.0000
543 BACK PAIN 8 0.0000
544 RASH 15 0.0000
545 LIVER FUNCTION TEST ABNORMAL 1 0.0000
546 DYSSTASIA 1 0.0000
547 ERYTHEMA 7 0.0000
548 NASAL CONGESTION 2 0.0000
549 ABDOMINAL PAIN UPPER 7 0.0000
550 BLADDER CANCER 2 0.0000
551 WHEEZING 2 0.0000
552 FEELING ABNORMAL 8 0.0000
553 APHASIA 1 0.0000
554 LACRIMATION INCREASED 1 0.0000
555 PLEURAL EFFUSION 2 0.0000
556 VERTIGO 2 0.0000
557 EMOTIONAL DISORDER 1 0.0000
558 FEMUR FRACTURE 1 0.0000
559 SWOLLEN TONGUE 1 0.0000
560 DRUG-INDUCED LIVER INJURY 1 0.0000
561 DRUG INTERACTION 5 0.0000
562 MOOD SWINGS 1 0.0000
563 GAIT DISTURBANCE 6 0.0000
564 METABOLIC ACIDOSIS 1 0.0000
565 PRURITUS 12 0.0000
566 HIP FRACTURE 1 0.0000
567 NIGHT SWEATS 1 0.0000
568 AMNESIA 2 0.0000
569 OSTEONECROSIS 1 0.0000
570 LIP SWELLING 1 0.0000
571 NEOPLASM MALIGNANT 2 0.0000
572 GAIT INABILITY 1 0.0000
573 MYALGIA 5 0.0000
574 HAEMATURIA 1 0.0000
575 GASTRIC DISORDER 1 0.0000
576 NIGHTMARE 1 0.0000
577 DELIRIUM 1 0.0000
578 ABDOMINAL DISTENSION 3 0.0000
579 RASH MACULAR 1 0.0000
580 HYPERKALAEMIA 1 0.0000
581 COVID-19 5 0.0000
582 LYMPHADENOPATHY 1 0.0000
583 SKIN BURNING SENSATION 2 0.0000
584 MOBILITY DECREASED 2 0.0000
585 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
586 C-REACTIVE PROTEIN INCREASED 1 0.0000
587 HYPERGLYCAEMIA 1 0.0000
588 MUSCLE SPASMS 5 0.0000
589 DYSURIA 1 0.0000
590 DYSPNOEA EXERTIONAL 1 0.0000
591 COLITIS 1 0.0000
592 CONFUSIONAL STATE 4 0.0000
593 ABDOMINAL DISCOMFORT 4 0.0000
594 PYREXIA 8 0.0000
595 MALAISE 10 0.0000
596 ANGIOEDEMA 1 0.0000
597 LIVER DISORDER 1 0.0000
598 PULMONARY OEDEMA 1 0.0000
599 THROAT IRRITATION 1 0.0000
600 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
601 SKIN IRRITATION 1 0.0000
602 SKIN DISCOLOURATION 1 0.0000
603 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
604 HYPERSENSITIVITY 4 0.0000
605 COGNITIVE DISORDER 1 0.0000
606 CARDIAC DISORDER 2 0.0000
607 PULMONARY EMBOLISM 2 0.0000
608 FALL 7 0.0000
609 MIGRAINE 2 0.0000
610 HYPOAESTHESIA 3 0.0000
611 SINUSITIS 2 0.0000
612 NERVOUSNESS 1 0.0000
613 HAEMORRHAGE 2 0.0000
614 PARAESTHESIA 3 0.0000
615 DEPRESSED MOOD 1 0.0000
616 INSOMNIA 5 0.0000
617 OEDEMA 1 0.0000
618 INFLUENZA 2 0.0000
619 URTICARIA 3 0.0000
620 NECK PAIN 1 0.0000
621 COUGH 5 0.0000
622 BLISTER 1 0.0000
623 OXYGEN SATURATION DECREASED 1 0.0000
624 TOXICITY TO VARIOUS AGENTS 3 0.0000
625 FLATULENCE 1 0.0000
626 MUSCULAR WEAKNESS 2 0.0000
627 HEADACHE 11 0.0000
628 DYSPHONIA 1 0.0000
629 JOINT SWELLING 2 0.0000
630 DISCOMFORT 1 0.0000
631 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
632 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
633 PRODUCT USE ISSUE 3 0.0000
634 DYSPNOEA 9 0.0000
635 LOSS OF CONSCIOUSNESS 2 0.0000
636 RENAL FAILURE 2 0.0000
637 SOMNOLENCE 3 0.0000
638 NEUTROPENIA 2 0.0000
639 HEPATIC ENZYME INCREASED 1 0.0000
640 MEMORY IMPAIRMENT 2 0.0000
641 BURNING SENSATION 1 0.0000
642 DEVICE MALFUNCTION 1 0.0000
643 SLEEP DISORDER 1 0.0000
644 HYPERTENSION 3 0.0000
645 RESPIRATORY FAILURE 1 0.0000
646 BRONCHITIS 1 0.0000
647 HOT FLUSH 1 0.0000
648 ACNE 1 0.0000
649 INCORRECT DOSE ADMINISTERED 3 0.0000
650 DIABETES MELLITUS 1 0.0000
651 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
652 INFLUENZA LIKE ILLNESS 1 0.0000
653 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
654 MUSCULOSKELETAL STIFFNESS 1 0.0000
655 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
656 BREAST CANCER 1 0.0000
657 BLOOD GLUCOSE INCREASED 2 0.0000
658 CONTUSION 1 0.0000
659 ATRIAL FIBRILLATION 1 0.0000
660 HEART RATE INCREASED 1 0.0000
661 DIZZINESS 5 0.0000
662 SYNCOPE 1 0.0000
663 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
664 CHEST DISCOMFORT 1 0.0000
665 WEIGHT INCREASED 2 0.0000
666 CHILLS 1 0.0000
667 PSORIASIS 1 0.0000
668 ANXIETY 2 0.0000
669 CONDITION AGGRAVATED 2 0.0000
670 TREMOR 1 0.0000
671 MYOCARDIAL INFARCTION 1 0.0000
672 NASOPHARYNGITIS 1 0.0000
673 CHEST PAIN 1 0.0000
674 DEPRESSION 1 0.0000